Search dm+d | Analyse prescribing for this drug | See prices paid for this drug and its variants
Name | Topiramate 25mg capsules |
BNF code | 040801050AAAVAV |
Virtual Therapeutic Moiety | Topiramate |
Date identifier became valid | 19 Oct 2018 |
Previous product identifier | 323033003 |
Basis of preferred name | rINN - Recommended International Non-proprietary |
Prescribing status | Valid as a prescribable product |
Sugar free | ✗ |
Gluten free | ✗ |
Preservative free | ✗ |
CFC free | ✗ |
Dose form | Discrete |
Unit dose form size | 1.000 |
Unit dose form units | capsule |
Unit dose unit of measure | capsule |
Virtual Product Ingredient | |
---|---|
Ingredient | Topiramate |
Basis of pharmaceutical strength | Based on Ingredient Substance |
Strength value numerator | 25.000 |
Strength value numerator unit | mg |
Ontology Drug Form & Route | |
Form & Route | capsule.oral |
Dose Form | |
Formulation | Oral capsule |
Drug Route | |
Route | Oral |
Controlled Drug Prescribing Information | |
Controlled Drug category | No Controlled Drug Status |
Actual Medicinal Products | |
Topamax 25mg sprinkle capsules (CST Pharma Ltd) | |
Topamax 25mg sprinkle capsules (Janssen-Cilag Ltd) | |
Topamax 25mg sprinkle capsules (Lexon (UK) Ltd) | |
Topamax 25mg sprinkle capsules (Necessity Supplies Ltd) | |
Virtual Medicinal Product Packs | |
Topiramate 25mg capsules 60 capsule |
dm+d data retrieved from TRUD: release NHSBSA_11.2.0_20241118000001, imported on 19th November 2024 at 03:53:26.